108 related articles for article (PubMed ID: 30315124)
1. Temporal autoregulation during human PU.1 locus SubTAD formation.
Schuetzmann D; Walter C; van Riel B; Kruse S; König T; Erdmann T; Tönges A; Bindels E; Weilemann A; Gebhard C; Wethmar K; Perrod C; Minderjahn J; Rehli M; Delwel R; Lenz G; Gröschel S; Dugas M; Rosenbauer F
Blood; 2018 Dec; 132(25):2643-2655. PubMed ID: 30315124
[TBL] [Abstract][Full Text] [Related]
2. Heterozygous deletion of the PU.1 locus in human AML.
Bonadies N; Pabst T; Mueller BU
Blood; 2010 Jan; 115(2):331-4. PubMed ID: 19890096
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of c-myc gene accompanied by PU.1 deficiency in radiation-induced acute myeloid leukemia in mice.
Hirouchi T; Takabatake T; Yoshida K; Nitta Y; Nakamura M; Tanaka S; Ichinohe K; Oghiso Y; Tanaka K
Exp Hematol; 2008 Jul; 36(7):871-85. PubMed ID: 18375040
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of Notch-1 expression decreases PU.1-mediated myeloid differentiation signaling in acute myeloid leukemia.
Chen PM; Yen CC; Wang WS; Lin YJ; Chu CJ; Chiou TJ; Liu JH; Yang MH
Int J Oncol; 2008 Jun; 32(6):1335-41. PubMed ID: 18497996
[TBL] [Abstract][Full Text] [Related]
5. The actin-binding protein CORO1A is a novel PU.1 (SPI1)- and CEBPA-regulated gene with significantly lower expression in APL and CEBPA-mutated AML patients.
Federzoni EA; Humbert M; Valk PJ; Behre G; Leibundgut EO; Torbett BE; Fey MF; Tschan MP
Br J Haematol; 2013 Mar; 160(6):855-9. PubMed ID: 23252456
[No Abstract] [Full Text] [Related]
6. Pharmacological inhibition of the transcription factor PU.1 in leukemia.
Antony-Debré I; Paul A; Leite J; Mitchell K; Kim HM; Carvajal LA; Todorova TI; Huang K; Kumar A; Farahat AA; Bartholdy B; Narayanagari SR; Chen J; Ambesi-Impiombato A; Ferrando AA; Mantzaris I; Gavathiotis E; Verma A; Will B; Boykin DW; Wilson WD; Poon GM; Steidl U
J Clin Invest; 2017 Dec; 127(12):4297-4313. PubMed ID: 29083320
[TBL] [Abstract][Full Text] [Related]
7. GATA-1 Inhibits PU.1 Gene via DNA and Histone H3K9 Methylation of Its Distal Enhancer in Erythroleukemia.
Burda P; Vargova J; Curik N; Salek C; Papadopoulos GL; Strouboulis J; Stopka T
PLoS One; 2016; 11(3):e0152234. PubMed ID: 27010793
[TBL] [Abstract][Full Text] [Related]
8. PU.1 and CEBPA expression in acute myeloid leukemia.
D'Alò F; Di Ruscio A; Guidi F; Fabiani E; Greco M; Rumi C; Hohaus S; Voso MT; Leone G
Leuk Res; 2008 Sep; 32(9):1448-53. PubMed ID: 18308386
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic control of hematopoiesis: the PU.1 chromatin connection.
van Riel B; Rosenbauer F
Biol Chem; 2014 Nov; 395(11):1265-74. PubMed ID: 25205721
[TBL] [Abstract][Full Text] [Related]
10. The Runx-PU.1 pathway preserves normal and AML/ETO9a leukemic stem cells.
Staber PB; Zhang P; Ye M; Welner RS; Levantini E; Di Ruscio A; Ebralidze AK; Bach C; Zhang H; Zhang J; Vanura K; Delwel R; Yang H; Huang G; Tenen DG
Blood; 2014 Oct; 124(15):2391-9. PubMed ID: 25185713
[TBL] [Abstract][Full Text] [Related]
11. PU.1 is regulated by NF-kappaB through a novel binding site in a 17 kb upstream enhancer element.
Bonadies N; Neururer Ch; Steege A; Vallabhapurapu S; Pabst T; Mueller BU
Oncogene; 2010 Feb; 29(7):1062-72. PubMed ID: 19966852
[TBL] [Abstract][Full Text] [Related]
12. A distal single nucleotide polymorphism alters long-range regulation of the PU.1 gene in acute myeloid leukemia.
Steidl U; Steidl C; Ebralidze A; Chapuy B; Han HJ; Will B; Rosenbauer F; Becker A; Wagner K; Koschmieder S; Kobayashi S; Costa DB; Schulz T; O'Brien KB; Verhaak RG; Delwel R; Haase D; Trümper L; Krauter J; Kohwi-Shigematsu T; Griesinger F; Tenen DG
J Clin Invest; 2007 Sep; 117(9):2611-20. PubMed ID: 17694175
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional Regulation of the Lineage-Determining Gene
Korczmar EA; Bookstaver AK; Ober E; Goldfarb AN; Tenen DG; Trinh BQ
Front Biosci (Schol Ed); 2024 May; 16(2):10. PubMed ID: 38939973
[TBL] [Abstract][Full Text] [Related]
14. Minimal PU.1 reduction induces a preleukemic state and promotes development of acute myeloid leukemia.
Will B; Vogler TO; Narayanagari S; Bartholdy B; Todorova TI; da Silva Ferreira M; Chen J; Yu Y; Mayer J; Barreyro L; Carvajal L; Neriah DB; Roth M; van Oers J; Schaetzlein S; McMahon C; Edelmann W; Verma A; Steidl U
Nat Med; 2015 Oct; 21(10):1172-81. PubMed ID: 26343801
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional regulators CITED2 and PU.1 cooperate in maintaining hematopoietic stem cells.
Mattes K; Geugien M; Korthuis PM; Brouwers-Vos AZ; Fehrmann RSN; Todorova TI; Steidl U; Vellenga E; Schepers H
Exp Hematol; 2019 May; 73():38-49.e7. PubMed ID: 30986495
[TBL] [Abstract][Full Text] [Related]
16. Forced FOG1 expression in erythroleukemia cells: Induction of erythroid genes and repression of myelo-lymphoid transcription factor PU.1.
Fujiwara T; Sasaki K; Saito K; Hatta S; Ichikawa S; Kobayashi M; Okitsu Y; Fukuhara N; Onishi Y; Harigae H
Biochem Biophys Res Commun; 2017 Apr; 485(2):380-387. PubMed ID: 28216155
[TBL] [Abstract][Full Text] [Related]
17. Inverse correlation between Flt3 and PU.1 expression in acute myeloblastic leukemias.
Inomata M; Takahashi S; Harigae H; Kameoka J; Kaku M; Sasaki T
Leuk Res; 2006 Jun; 30(6):659-64. PubMed ID: 16271760
[TBL] [Abstract][Full Text] [Related]
18. Combined Approach to Leukemic Differentiation Using Transcription Factor PU.1-Enhancing Agents.
Bašová P; Paszeková H; Minařík L; Dluhošová M; Burda P; Stopka T
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743167
[TBL] [Abstract][Full Text] [Related]
19. [Down-regulation of transcription factor PU.1 via abnormal epigenetic modification in chronic myeloid leukemia].
Yang H; Yan JS; Tao R; Hao SG; Liang H; Ma LY
Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):169-75. PubMed ID: 22780968
[TBL] [Abstract][Full Text] [Related]
20. 5-azacitidine in aggressive myelodysplastic syndromes regulates chromatin structure at PU.1 gene and cell differentiation capacity.
Curik N; Burda P; Vargova K; Pospisil V; Belickova M; Vlckova P; Savvulidi F; Necas E; Hajkova H; Haskovec C; Cermak J; Krivjanska M; Trneny M; Laslo P; Jonasova A; Stopka T
Leukemia; 2012 Aug; 26(8):1804-11. PubMed ID: 22343522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
